Literature DB >> 1691067

Bleomycin-induced pulmonary toxicity.

K Jules-Elysee1, D A White.   

Abstract

Bleomycin is recognized to cause an interstitial pneumonitis that can lead to fibrosis. Although its occurrence may be sporadic, some factors may increase the risk of such a pulmonary reaction. In this article the clinical setting and presentation, radiographic manifestations, pathologic findings, and the prognosis of bleomycin-induced interstitial fibrosis are described. Additionally, the role of pulmonary function tests in monitoring patients for toxicity is discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1691067

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  42 in total

Review 1.  Lung regeneration: a tale of mice and men.

Authors:  Maria C Basil; Edward E Morrisey
Journal:  Semin Cell Dev Biol       Date:  2019-11-21       Impact factor: 7.727

2.  Effects of erdosteine on bleomycin-induced lung fibrosis in rats.

Authors:  Haşim Boyaci; Hale Maral; Gupse Turan; Ilknur Başyiğit; Meltem O Dillioğlugil; Füsun Yildiz; Melih Tugay; Ayşe Pala; Cengiz Erçin
Journal:  Mol Cell Biochem       Date:  2006-01       Impact factor: 3.396

3.  Acute fibrinous and organising pneumonia: a rare histopathological variant of chemotherapy-induced lung injury.

Authors:  Arjun Gupta; Shiraj Sen; Harris Naina
Journal:  BMJ Case Rep       Date:  2016-04-06

4.  Severe bleomycin lung toxicity: reversal with high dose corticosteroids.

Authors:  J Maher; P A Daly
Journal:  Thorax       Date:  1993-01       Impact factor: 9.139

5.  Bleomycin lung: a case report.

Authors:  Rabia Sofia Rashid
Journal:  BMJ Case Rep       Date:  2009-04-14

6.  Chemotherapy and Radiation Induced Pulmonary Dysfunction in Hodgkin Lymphoma Patients.

Authors:  Sebnem Izmir Guner; Mustafa Teoman Yanmaz; Ahmet Selvi; Cigdem Usul
Journal:  Indian J Hematol Blood Transfus       Date:  2015-11-14       Impact factor: 0.900

Review 7.  Clinical and preclinical modulation of chemotherapy-induced toxicity in patients with cancer.

Authors:  K Hoekman; W J van der Vijgh; J B Vermorken
Journal:  Drugs       Date:  1999-02       Impact factor: 9.546

8.  Pulmonary toxicity in patients with non-Hodgkin's lymphoma treated with bleomycin-containing combination chemotherapy.

Authors:  H Y Ngan; R H Liang; W K Lam; T K Chan
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

9.  Pneumocystis pneumonia in a non-HIV patient on chronic corticosteroid therapy: a question of prophylaxis.

Authors:  Michael J Plakke; Leena Jalota; Benjamin J Lloyd
Journal:  BMJ Case Rep       Date:  2013-03-01

10.  Overexpression of fibroblast growth factor-10 during both inflammatory and fibrotic phases attenuates bleomycin-induced pulmonary fibrosis in mice.

Authors:  Varsha V Gupte; Suresh K Ramasamy; Raghava Reddy; Jooeun Lee; Paul H Weinreb; Shelia M Violette; Andreas Guenther; David Warburton; Barbara Driscoll; Parviz Minoo; Saverio Bellusci
Journal:  Am J Respir Crit Care Med       Date:  2009-06-04       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.